HIGHLIGHTS
- who: Qiuchi Chen and collaborators from the University of Texas MD Anderson Center, United States have published the research: Systemic treatments for breast cancer brain metastasis, in the Journal: (JOURNAL)
- how: In the JPBO study abemaciclib was given to HR+/HER2- BCBM patients and the results showed that 25% of patients did achieve clinical benefit (CR PR or SD>6 months) but definite intracranial ORR was only 5.6% .
SUMMARY
In 2020, the incidence of breast cancer (BC) surpassed lung cancer and was ranked first, accounting for 11.7% of all . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.